Skip to main content

Geospiza Closes $3M in Financing

NEW YORK (GenomeWeb News) - Geospiza today said it has completed a $3 million round of series A stock financing.
 
Geospiza, which sells genomic data-management software, said it intends to use the funds to add product and sales staff to meet increasing demand.
 
The company said it will also use the funds to expand a collaboration with Applied Biosystems that the companies began in 2005 and expanded in August.
 
Geospiza said that the development of new tests for cancer and infectious disease is driving demand for its software, and that its customers are seeing increased pressure to "streamline their analytical procedures and reduce testing backlog."

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.